Profile data is unavailable for this security.
About the company
RPG Life Sciences Limited is an India-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has presence in over 10 therapeutic areas, including nephrology, oncology, rheumatology, cardiology, respiratory, nutritional, gastroenterology, and diabetology, among others. The international formulations business is involved in developing, manufacturing and marketing oral solid formulations in the generic and branded generic space across regulated and emerging markets. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Sodium Valproate PR, Nicorandil, Quinfamide, Nicorandil, Haloperidol, Risperidone, and others.
- Revenue in INR (TTM)5.82bn
- Net income in INR876.60m
- Incorporated2007
- Employees1.17k
- LocationRPG Life Sciences LimitedRPG House463, Dr. Annie Besant Road, WorliMUMBAI 400030IndiaIND
- Phone+91 2 224981650
- Fax+91 2 224970127
- Websitehttps://www.rpglifesciences.com/website/index.php
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ngl Fine Chem Ltd | 3.17bn | 380.04m | 15.54bn | 343.00 | 40.89 | -- | 31.25 | 4.90 | 61.52 | 61.52 | 513.13 | -- | -- | -- | -- | 9,241,813.00 | -- | 15.74 | -- | 20.73 | 53.94 | 45.27 | 11.99 | 13.43 | -- | 34.92 | -- | 3.47 | -12.42 | 19.17 | -58.92 | 10.23 | 5.65 | -- |
| SMS Pharmaceuticals Ltd | 6.13bn | 360.58m | 17.00bn | 1.10k | 47.11 | -- | 23.50 | 2.77 | 4.26 | 4.26 | 72.40 | -- | -- | -- | -- | 5,597,176.00 | -- | 5.86 | -- | 7.77 | 31.67 | 33.18 | 6.65 | 8.34 | -- | 3.13 | -- | 6.26 | 0.4188 | 2.35 | -111.35 | -- | 28.46 | 3.71 |
| Themis Medicare Ltd | 3.64bn | 452.86m | 19.80bn | 996.00 | 43.79 | -- | 34.57 | 5.44 | 4.91 | 4.91 | 39.49 | -- | -- | -- | -- | 3,655,101.00 | -- | 9.59 | -- | 14.94 | 65.58 | 60.13 | 12.44 | 13.15 | -- | -- | -- | 7.33 | -10.21 | 10.85 | -21.93 | 38.18 | 24.51 | -- |
| Solara Active Pharma Sciences Ltd | 14.07bn | -3.08bn | 19.93bn | 2.36k | -- | -- | -- | 1.42 | -85.65 | -85.65 | 390.73 | -- | -- | -- | -- | 5,958,916.00 | -- | 2.68 | -- | 4.10 | 40.47 | 44.49 | -21.88 | 4.58 | -- | -1.67 | -- | 10.10 | 13.83 | 22.61 | 61.86 | -- | 26.23 | -- |
| Amrutanjan Health Care Ltd | 3.94bn | 440.09m | 22.41bn | 575.00 | 51.28 | -- | 44.97 | 5.68 | 15.13 | 15.13 | 135.41 | -- | -- | -- | -- | 6,860,612.00 | -- | 17.04 | -- | 21.22 | 49.51 | 54.08 | 11.16 | 13.37 | -- | 341.76 | -- | 17.21 | -6.46 | 11.37 | -40.71 | 14.72 | 23.87 | 10.64 |
| RPG Life Sciences Limited | 5.82bn | 876.60m | 24.34bn | 1.17k | 27.76 | 6.49 | 23.24 | 4.18 | 53.01 | 53.01 | 351.99 | 226.65 | 1.25 | 1.88 | 13.45 | -- | 18.81 | 16.07 | 25.10 | 21.77 | 68.30 | 64.04 | 15.06 | 11.99 | 1.50 | 246.84 | 0.00 | 29.27 | 13.50 | 12.01 | 29.60 | 51.98 | 28.60 | 46.14 |
| Suven Life Sciences Ltd | 119.19m | -1.06bn | 24.81bn | 132.00 | -- | -- | -- | 208.12 | -5.20 | -5.20 | 0.5759 | -- | -- | -- | -- | 902,939.40 | -- | -31.29 | -- | -35.32 | -- | 66.93 | -890.87 | -127.02 | -- | -744.27 | -- | -- | 14.31 | -53.54 | 3.06 | -- | -41.37 | -- |
| Morepen Laboratories Ltd | 16.31bn | 761.19m | 25.38bn | 1.65k | 32.90 | -- | 23.73 | 1.56 | 1.51 | 1.51 | 32.53 | -- | -- | -- | -- | 9,891,111.00 | -- | 7.39 | -- | 13.78 | 35.85 | 32.82 | 4.67 | 5.19 | -- | 27.34 | -- | 0.00 | -8.36 | 18.51 | -61.96 | 5.50 | 11.33 | -- |
| Innova Captab Ltd | -100.00bn | -100.00bn | 26.23bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 15.72 | -- | 6.26 | -- | -- | -- |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 26.30bn | 1.23k | -- | 83.17 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
| SeQuent Scientific Ltd | 13.75bn | -1.29bn | 30.17bn | 478.00 | -- | -- | -- | 2.19 | -5.18 | -5.18 | 55.33 | -- | -- | -- | -- | 28,769,920.00 | -- | 2.33 | -- | 3.67 | 42.78 | 42.47 | -8.97 | 2.59 | -- | -0.3894 | -- | 17.27 | 0.5728 | 10.84 | -395.83 | -- | 12.88 | -- |
| Indoco Remedies Ltd | 17.96bn | 1.02bn | 31.13bn | 6.10k | 30.90 | -- | 16.91 | 1.73 | 10.93 | 10.93 | 192.26 | -- | -- | -- | -- | 2,943,454.00 | -- | 6.07 | -- | 8.90 | 69.39 | 65.35 | 5.61 | 6.30 | -- | 5.11 | -- | 14.79 | 8.30 | 9.81 | -8.11 | 28.15 | 8.25 | 17.61 |
| Gufic BioSciences Ltd | 7.85bn | 841.95m | 32.31bn | 1.63k | 37.37 | -- | 30.63 | 4.12 | 8.62 | 8.62 | 80.38 | -- | -- | -- | -- | 4,820,074.00 | -- | 12.30 | -- | 23.08 | 51.08 | 44.91 | 10.73 | 9.84 | -- | 8.22 | -- | 1.39 | -11.36 | 17.47 | -16.84 | 37.06 | 86.82 | 14.87 |
| Supriya Lifescience Ltd | 5.54bn | 1.20bn | 33.04bn | 392.00 | 27.42 | -- | 24.42 | 5.96 | 14.97 | 14.97 | 68.93 | -- | -- | -- | -- | 14,144,410.00 | -- | 20.77 | -- | 29.06 | 61.94 | 55.83 | 21.72 | 24.33 | -- | 63.63 | -- | 2.02 | -13.04 | 16.70 | -40.81 | 59.41 | 85.55 | -- |
Data as of May 03 2024. Currency figures normalised to RPG Life Sciences Limited's reporting currency: Indian Rupee INR
1.59%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Mirae Asset Investment Managers (India) Pvt Ltd.as of 31 Mar 2024 | 235.59k | 1.42% |
| American Century Investment Management, Inc.as of 04 Apr 2024 | 8.85k | 0.05% |
| Acadian Asset Management LLCas of 30 Sep 2023 | 7.97k | 0.05% |
| WhiteOak Capital Asset Management Ltd.as of 31 Mar 2024 | 7.45k | 0.05% |
| State Board of Administration of Florida Retirement Systemas of 30 Jun 2023 | 2.05k | 0.01% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 469.00 | 0.00% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Mar 2024 | 58.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 15 Apr 2024Source: FactSet Research Systems Inc.
